fda news tirzepatide judge BREAKING NEWS: Grills Over Access—Here's What It Means for You Court Dismisses Another Lawsuit Targeting – Eli Lilly seeks FDA approval

Oral semaglutide (Rybelsus) is FDA-approved for type 2 diabetes management only, not for weight management

Your provider adjusts tirzepatide based on your weekly weight loss, tolerability, and metabolic markersprecise unit-to-milligram understanding ensures alignment between prescription intent and actual intake

Watch for these symptoms: Dry mouth Dark urine Dizziness Palpitations Marked weakness Seek medical advice if symptoms are persistent or severe

Portable x-ray fluorescence(PXRF)was used to determine the minerals and elements that are lost due to dental erosion and scanning electron microscopy(SEM) highlighted the structural changes and damages that occurred